| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 8.869.963 $ | 99,35 | 2.186.443 | |||||||
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 358.280 $ | 4,01 | 47.707 | |
| Precigen Inc | Precigen Inc | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 272.330 $ | 3,05 | 157.416 | |
| Compass Therapeutics Inc | Compass Therapeutics Inc | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 266.910 $ | 2,99 | 92.038 | |
| Genelux Corp | Genelux Corp | EC | 36870H103 | Long | Börsenkurs (Stufe 1) | 259.005 $ | 2,90 | 61.963 | |
| SpringWorks Therapeutics Inc | SpringWorks Therapeutics Inc | EC | 85205L107 | Long | Börsenkurs (Stufe 1) | 255.646 $ | 2,86 | 4.426 | |
| Exelixis Inc | Exelixis Inc | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 221.694 $ | 2,48 | 5.730 | |
| Ginkgo Bioworks Holdings Inc | Ginkgo Bioworks Holdings Inc | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 208.167 $ | 2,33 | 25.263 | |
| Replimune Group Inc | Replimune Group Inc | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 190.796 $ | 2,14 | 15.047 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 187.743 $ | 2,10 | 3.149 | |
| Schrodinger Inc/United States | Schrodinger Inc/United States | EC | 80810D103 | Long | Börsenkurs (Stufe 1) | 176.807 $ | 1,98 | 7.925 | |
| Blueprint Medicines Corp | Blueprint Medicines Corp | EC | 09627Y109 | Long | Börsenkurs (Stufe 1) | 176.144 $ | 1,97 | 1.824 | |
| Zymeworks Inc | Zymeworks Inc | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 168.585 $ | 1,89 | 12.581 | |
| Vor BioPharma Inc | Vor BioPharma Inc | EC | 929033108 | Long | Börsenkurs (Stufe 1) | 168.293 $ | 1,88 | 155.827 | |
| HUTCHMED China Ltd | HUTCHMED China Ltd | EC | 44842L103 | Long | Börsenkurs (Stufe 1) | 156.732 $ | 1,76 | 9.522 | |
| Innate Pharma SA | Innate Pharma SA | EC | 45781K204 | Long | Börsenkurs (Stufe 1) | 154.113 $ | 1,73 | 72.695 | |
| Monte Rosa Therapeutics Inc | Monte Rosa Therapeutics Inc | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 154.028 $ | 1,73 | 28.005 | |
| ImmunityBio Inc | ImmunityBio Inc | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 148.369 $ | 1,66 | 45.097 | |
| Merus NV | Merus NV | EC | NL0011606264 | Long | Börsenkurs (Stufe 1) | 147.674 $ | 1,65 | 3.136 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 146.497 $ | 1,64 | 7.033 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 143.975 $ | 1,61 | 3.534 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 143.973 $ | 1,61 | 1.275 | |
| Immunocore Holdings PLC | Immunocore Holdings PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 140.095 $ | 1,57 | 4.770 | |
| Syndax Pharmaceuticals Inc | Syndax Pharmaceuticals Inc | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 135.255 $ | 1,51 | 8.648 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 134.288 $ | 1,50 | 5.921 | |
| Arcellx Inc | Arcellx Inc | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 132.557 $ | 1,48 | 2.045 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 123.154 $ | 1,38 | 1.335 | |
| Inhibrx Biosciences Inc | Inhibrx Biosciences Inc | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 119.648 $ | 1,34 | 9.030 | |
| Aura Biosciences Inc | Aura Biosciences Inc | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 118.245 $ | 1,32 | 15.787 | |
| Xencor Inc | Xencor Inc | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 114.309 $ | 1,28 | 7.442 | |
| MacroGenics Inc | MacroGenics Inc | EC | 556099109 | Long | Börsenkurs (Stufe 1) | 112.877 $ | 1,26 | 45.885 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 111.197 $ | 1,25 | 57.024 | |
| Arvinas Inc | Arvinas Inc | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 110.784 $ | 1,24 | 6.259 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 110.485 $ | 1,24 | 5.340 | |
| Karyopharm Therapeutics Inc | Karyopharm Therapeutics Inc | EC | 48576U205 | Long | Börsenkurs (Stufe 1) | 108.981 $ | 1,22 | 13.708 | |
| Legend Biotech Corp | Legend Biotech Corp | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 107.446 $ | 1,20 | 3.069 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 105.272 $ | 1,18 | 1.404 | |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc | EC | 23954D109 | Long | Börsenkurs (Stufe 1) | 104.616 $ | 1,17 | 11.547 | |
| Janux Therapeutics Inc | Janux Therapeutics Inc | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 103.768 $ | 1,16 | 3.155 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 101.793 $ | 1,14 | 3.247 | |
| Acrivon Therapeutics Inc | Acrivon Therapeutics Inc | EC | 004890109 | Long | Börsenkurs (Stufe 1) | 101.548 $ | 1,14 | 19.124 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 101.419 $ | 1,14 | 9.313 | |
| Nuvation Bio Inc | Nuvation Bio Inc | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 100.994 $ | 1,13 | 51.266 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 95.727 $ | 1,07 | 137 | |
| Nurix Therapeutics Inc | Nurix Therapeutics Inc | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 95.589 $ | 1,07 | 6.187 | |
| RAPT Therapeutics Inc | RAPT Therapeutics Inc | EC | 75382E109 | Long | Börsenkurs (Stufe 1) | 95.436 $ | 1,07 | 83.716 | |
| iTeos Therapeutics Inc | iTeos Therapeutics Inc | EC | 46565G104 | Long | Börsenkurs (Stufe 1) | 94.438 $ | 1,06 | 13.008 | |
| Adicet Bio Inc | Adicet Bio Inc | EC | 007002108 | Long | Börsenkurs (Stufe 1) | 94.306 $ | 1,06 | 104.924 | |
| Tyra Biosciences Inc | Tyra Biosciences Inc | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 91.467 $ | 1,02 | 7.811 | |
| Caribou Biosciences Inc | Caribou Biosciences Inc | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 90.710 $ | 1,02 | 77.530 | |
| Immuneering Corp | Immuneering Corp | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 90.483 $ | 1,01 | 54.838 | |
| Lyell Immunopharma Inc | Lyell Immunopharma Inc | EC | 55083R104 | Long | Börsenkurs (Stufe 1) | 90.217 $ | 1,01 | 126.923 | |
| Zentalis Pharmaceuticals Inc | Zentalis Pharmaceuticals Inc | EC | 98943L107 | Long | Börsenkurs (Stufe 1) | 88.530 $ | 0,99 | 42.768 | |
| Ideaya Biosciences Inc | Ideaya Biosciences Inc | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 87.916 $ | 0,98 | 4.274 | |
| 2seventy bio Inc | 2seventy bio Inc | EC | 901384107 | Long | Börsenkurs (Stufe 1) | 86.383 $ | 0,97 | 32.721 | |
| Foghorn Therapeutics Inc | Foghorn Therapeutics Inc | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 82.435 $ | 0,92 | 16.997 | |
| Cullinan Therapeutics Inc | Cullinan Therapeutics Inc | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 78.923 $ | 0,88 | 9.296 | |
| Apollomics Inc | Apollomics Inc | EC | KYG0411D1236 | Long | Börsenkurs (Stufe 1) | 78.111 $ | 0,87 | 11.835 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 76.461 $ | 0,86 | 55.811 | |
| Agenus Inc | Agenus Inc | EC | 00847G804 | Long | Börsenkurs (Stufe 1) | 73.775 $ | 0,83 | 25.886 | |
| Bicycle Therapeutics PLC | Bicycle Therapeutics PLC | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 69.155 $ | 0,77 | 6.304 | |
| Autolus Therapeutics PLC | Autolus Therapeutics PLC | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 68.070 $ | 0,76 | 39.347 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 67.946 $ | 0,76 | 16.044 | |
| Sutro Biopharma Inc | Sutro Biopharma Inc | EC | 869367102 | Long | Börsenkurs (Stufe 1) | 67.634 $ | 0,76 | 42.537 | |
| Y-mAbs Therapeutics Inc | Y-mAbs Therapeutics Inc | EC | 984241109 | Long | Börsenkurs (Stufe 1) | 67.265 $ | 0,75 | 12.098 | |
| Relay Therapeutics Inc | Relay Therapeutics Inc | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 66.178 $ | 0,74 | 19.407 | |
| Geron Corp | Geron Corp | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 63.386 $ | 0,71 | 36.015 | |
| Kura Oncology Inc | Kura Oncology Inc | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 58.149 $ | 0,65 | 7.542 | |
| Biomea Fusion Inc | Biomea Fusion Inc | EC | 09077A106 | Long | Börsenkurs (Stufe 1) | 56.999 $ | 0,64 | 19.723 | |
| Repare Therapeutics Inc | Repare Therapeutics Inc | EC | 760273102 | Long | Börsenkurs (Stufe 1) | 55.939 $ | 0,63 | 47.406 | |
| Immatics NV | Immatics NV | EC | NL0015285941 | Long | Börsenkurs (Stufe 1) | 54.154 $ | 0,61 | 12.364 | |
| Prelude Therapeutics Inc | Prelude Therapeutics Inc | EC | 74065P101 | Long | Börsenkurs (Stufe 1) | 45.945 $ | 0,51 | 60.533 | |
| Fate Therapeutics Inc | Fate Therapeutics Inc | EC | 31189P102 | Long | Börsenkurs (Stufe 1) | 44.513 $ | 0,50 | 39.744 | |
| Mersana Therapeutics Inc | Mersana Therapeutics Inc | EC | 59045L106 | Long | Börsenkurs (Stufe 1) | 41.815 $ | 0,47 | 79.891 | |
| Tango Therapeutics Inc | Tango Therapeutics Inc | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 33.902 $ | 0,38 | 16.378 | |
| IGM Biosciences Inc | IGM Biosciences Inc | EC | 449585108 | Long | Börsenkurs (Stufe 1) | 13.513 $ | 0,15 | 9.936 | |
| 8.869.963 $ | 99,35 | 2.186.443 |